STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 22nd, 2017 • OphthaliX, Inc. • Pharmaceutical preparations
This STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of _______________, 2017 by and between OphthaliX, Inc., a Delaware corporation (the “Company”) and Can-Fite Biopharma Ltd. (“Can-Fite”).
Agreement and Plan of MergerMerger Agreement • May 22nd, 2017 • OphthaliX, Inc. • Pharmaceutical preparations
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of the 21st day of May 2017, by and among OphthaliX Inc., a Delaware corporation (“OPLI”), Bufiduck Ltd., a corporation established under the laws of the State of Israel and a wholly-owned subsidiary of OPLI (the “Merger Sub”); and Wize Pharma Ltd., a corporation established under the laws of the State of Israel (the “Company”). OPLI, the Merger Sub and the Company are at times collectively referred to herein individually as a “Party” and collectively as the “Parties.”
TERMINATION OF SERVICES AGREEMENTTermination of Services Agreement • May 22nd, 2017 • OphthaliX, Inc. • Pharmaceutical preparations
THIS TERMINATION OF SERVICES AGREEMENT (this “Agreement”) made as of this _____________, 2017 (the “Effective Date”) by and between CAN-FITE BIOPHARMA LTD., an Israeli-registered public company whose principal place of business is located at 10 Bareket Street, Petach Tikva, Israel ( “CanFite”), OPHTHALIX INC., a Delaware-registered company, whose principal place of business is located at 10 Bareket Street, Petach Tikva, Israel ("OphthaliX"), and its wholly owned subsidiary, EYEFITE LTD., an Israeli-registered private company whose principal place of business is located at 12 Abba Hillel Silver, Ramat Gan 52506 , Israel ("EyeFite" and together with OphthaliX, the “Companies” and Can-Fite, Eyefite and OphthaliX, each a “Party”).
TERMINATION OF LICENSE AGREEMENTTermination Agreement • May 22nd, 2017 • OphthaliX, Inc. • Pharmaceutical preparations
This Termination Agreement (this “Termination Agreement”), dated ________, 2017 (the “Effective Date”), is made by and between CAN-FITE Biopharma Ltd., a public company incorporated under the laws of the State of Israel (“CANFITE”), and Eye-Fite Ltd., a private company incorporated under the laws of the State of Israel (“EYEFITE”). CANFITE and EYEFITE are sometimes hereinafter referred to each as a “Party” and collectively as the “Parties.”
